Interferon Induces the Production of Membrane Protein-deficient and Infectivity-defective Vesicular Stomatitis Virions through Interference in
the Virion Assembly Process (Accepted 31 September 1982) SUMMARY The reduced rate of synthesis, maturation and degradation as well as the level of accumulation of the intracellular virus proteins in VSV-infected ceils may account for the overall reduction (less than 10-fold) of progeny virion yield due to interferon (IFN); however, the deficiency of the virions proteins, G and M, which apparently caused a drastic loss of infectivity of these progeny virions (about 1000-fold) cannot be easily explained, because the concentrations of G and M proteins relative to other virus proteins were not reduced in the cell. In fact, intraceUular M protein was significantly increased. Moreover, the virus proteins in IFN-treated and control cells were synthesized and accumulated in large excess of the amount incorporated into the released virions. The reduction in the intracellular activity of GIcNac-P-P-Dol transferase did not appear to play a direct role in the antiviral mechanism in this system. Our results, however, do suggest that the deficiency of G and M proteins in the virion is related to specific inhibition of the incorporation of either or both of these proteins in the virus assembly process.
Interferon (IFN) inhibits murine leukaemia viruses (MuLV) at a late step in the virus productive process (Billiau et al., 1974; Friedman & Ramseur, 1974; Pitha et al., 1976; Billiau et al., 1975) , while translation of virus proteins is apparently not affected. The inhibitory effect of IFN on these viruses can be expressed in one of two ways: (i) IFN caused a drastic reduction in the release of the virus particles from the cell membrane (Billiau et aL 1974; Friedman et al., 1975; Chang et al., 1977 Chang et al., , 1978 and the budding virions were found to accumulate on the plasma membrane surface (Chang et al., 1977) ; or (ii) the effect of IFN was expressed as a dramatic reduction of the infectivity of the progeny virions, while the number of virions produced was only marginally reduced (Pitha et al., 1976; Wong et al., 1977) . In both cases, the synthesis of the major virus proteins did not appear to be affected significantly, arguing against any major virus inhibitory effect involving the translational process.
We have recently extended the observation of this mode of IFN antiviral action to vesicular stomatitis virus (VSV) replication. The pretreatment of LB cells with 50 IU/ml IFN (international mouse reference unit) inhibited VSV particle yield by less than 10-fold, but the infectivity of the progeny was reduced by 100-to 1000-fold (Maheshwari et al., 1980a) . The defective progeny virions (VSVIF) were found to have reduced amounts of the G and M proteins. This may account for the low infectivity of the VSVIF since the efficiency of. VSV infectivity depends directly on the presence of G protein (Bishop et al., 1975) . In an attempt to understand the mechanism of the antiviral action causing the deficiency of G and M proteins, which apparently resulted in the dramatic loss of infectivity in the progeny virions, we have studied the effect of IFN treatment on the rate of synthesis, maturation, degradation, and intracellular accumulation of the VSV proteins. (b) Fig. I . LB cells were either IFN-treated (25 IU/ml) or mock-treated for 18 h prior to infection with VSV at 10 p.f.u./cell. At 5 h post-infection, the cultures were pulse-labelled with [35S]methionine at 50 ~tCi/ml, 1.5 ~tg/ml for 7 min, and chased for 5, 10, 20, 40 and 150 rain. At the end of the chase period, the cultures were floated on an ice-water bath, washed three times with cold TBS (25 mM-Tris-HC1, pH 7.5, 100 mM-NaCI) and solubilized in TBS containing 1~ Nonidet P40, 0.1~ SDS and 2 mMphenylmethylsulphonyl fluoride. (a) The cell lysates (12 ~tg) were analysed by SDS-PAGE and visualized by fluorography after denaturation in 2~ SDS and 5~ 2-mercaptoethanol at 100 °C for 2 min as described previously. Mock-treated (lanes 1 to 6) and IFN-treated (lanes 8 to 13) were pulselabelled for 7 min (lanes 1 and 8) and chased for 5 min (lanes 2 and 9), 10 min (lane 3 and 10), 20 min (lanes 4 and 11), 40 min (lanes 5 and 12) and 120 min (lanes 6 and 13). Mol. wt. markers (lane 7), which were 14C-methylated were phosphorylase B (92-5 kdal), bovine serum albumin (69 kdal), ovalbumin (46 kdal) and carbonic anhydrase (30 kdal). (b) Native samples of the mock-treated (c) and IFN-treated (d) pulse-labelled cultures as in (a), lanes 1 and 8 respectively, were analysed by two-dimensional gel etectrophoresis with isoelectric focusing, pH 3-5 to I0. Mock-treated cells (a) and 1-5gg/ml tunicamycin-treated cells (b) were similarly analysed to demonstrate the expected location of the mature VSV glycoproteins (G) and the underglycosylated G (pG). Subscripts to 'G' denote the number of negative charges (sialic acid residue) more than that of the pG polypeptide.
by about 30% in the IFN-treated culture. Fig. 1 (a) shows the fluorograph (Laskey & Mills, 1975) of the SDS-PAGE analysis (Laemmli, 1970) of the cell lysates. No unglycosylated polypeptide G (pG) was detected even in a short pulse, suggesting that glycosylation proceeded on nascent peptide chains, and not on completed peptide chains. Almost all of the G-related peptides detectable after the 7 min pulse had the molecular weights expected for G with almost all of its carbohydrate already added (Fig. I a, lane 1) , and lacking only sialic acid residues (Fig. I b, c) ; however, G protein increased in mol. wt. (Fig. I a, 1 to 6 ) with increased chase time, indicating that the last steps of the glycosylation process, the addition of sialic acid residues, were relatively slow. The IFN-treated cultures appeared to have similar kinetics (Fig. 1 a, 8 to 13 ). The protein of mol. wt. 55 to 58 kdal that rapidly turned over was not the pG, and is not likely to be G-related because its pI (Fig. 1 b, c) was lower than those of pG ( Fig. 1 b, b) or Go (Fig. 1 b, a) . The subscripts indicate the number of negative charges more than pG. All the virus proteins appeared to be very stable, at least within the 150 min chase. Other experiments indicated that the degradation of VSV proteins was not detectable over several hours.
In order to test whether IFN affected the structure and maturation of the G protein, an abnormality that might explain the reduced incorporation of mature G into the virion, pulselabelled, VSV-infected cells were harvested, and the proteins were analysed by 2D-PAGE ( Fig.  1 b, c and d) . Fig. 1 (b) , a and b, demonstrate the location of the family of mature G proteins (Go to G7) from control virions and virions produced by cells in the presence of tunicamycin (1.5 ~tg/ml) which inhibits glycosylation (pG has been abbreviated as G O by others; however, pG is used here to distinguish it from Go, the species of glycosylated G protein that does not contain any sialic acid). In a 7 min pulse ( Fig. 1 b, c ) the major G-related polypeptides labelled were the G O species, representing the polypeptide fully (or nearly fully) glycosylated with the neutral sugars, but with no sialic acid, and G1, a species of G that has an extra negative charge due to one sialic acid residue. Little or no unglycosylated G polypeptide, pG (as seen in Fig. I b, c) , was found in the control, even in a 7 min pulse, again suggesting that glycosylation was carried out on the nascent polypeptide chain, and that the process was at least as efficient as the translation process, because no intermediate was detectable. Furthermore, the addition of the first sialic acid residue appeared to be very rapid, and the remaining residues were added relatively slowly over 150 min (Fig. l b, c) , indicating that there was an abrupt change in the kinetics of sialylation. On the basis of net charge and mol. wt., no change in the quality of VSV proteins was detectable after IFN treatment (Fig. 1 b, d) , and the kinetics and pattern of glycosylation was not altered. The observation that VSVIv was deficient in membrane proteins is, therefore, probably due to an impairment in a step(s) subsequent to the synthesis and glycosylation of the G protein.
In order to test whether the accumulation of G and M proteins was inhibited more than the other VSV proteins, we measured the relative levels of accumulation of the virus proteins. Mockand IFN-treated (25 IU/ml) cells were infected with VSV at 10 p.f.u./cell and virus proteins were labelled from 4-5 h to 18 h post-infection. The virus proteins in the cell lysate were analysed by SDS-PAGE and the individual labelled VSV protein in each sample was located by autoradiography, excised from the gel, and the radioactivity was quantified. The amount of G and M proteins in each sample was normalized to the unit concentration of N protein in order to compare the relative concentration of G protein in different samples. The results presented in Table 1 are the concentrations relative to the control which is taken to be one and the IFN dosedependent reduction in the yield of infectious virus. The inhibition was more than 1000-fold at a dose of 50 IU/ml; however, the relative amount of intracellular G protein remained fairly constant over the whole range of IFN concentrations tested. Indeed, the relative amount of M protein increased significantly by about 67 ~ at 50 IU/ml. These findings are just the opposite of those observed in the extracellular progeny virion, in which the G and M protein content were found to be significantly reduced (Maheshwari et al., 1980b) . The decreased incorporation of G and M proteins into VSVIF produced by IFN-treated LB cells was, therefore, not due to specific inhibition of the translation or accumulation of G and M proteins. This phenomenon was not likely to be due to a general decrease in the synthesis or the intracellular accumulation of VSV proteins, because the amount of intracellular virus proteins that was assembled into released Table 1 .
Short communications Relative concentrations of the intracellular virus proteins accumulated in the IFN-treated cell
Infectivity Relative Relative IFN dose yield concn, of concn, of (IU/ml)* (loglo TCIDso/ml)t G proteins M proteins 0 9.11 1-00 1-00 5 8-20 1-02 1 "10 10 7-81 0-96 1.23 20 6.20 0-96 1 "37 50 5-90 1-02 1 "67 * International mouse IFN reference unit; IFN treatment began 18 h before infection and continued throughout the course of the infection until 16 h post-infection.
t Infectivity yield was measured by tissue culture infectious dose per ml in an assay for cytopathic effect. :~ Calculated from the ratio of the protein-specific ct/min to N protein-specific ct/min and expressed as relative to that (ratio) of the control which is taken as 1.00.
virus particles was less than 9% of the total virus protein production in control cells, and less than 3% in cells treated with 20 IU/ml IFN (data not shown). The intracellular pool of virus proteins was, therefore, in large excess of the amount required for virus assembly; moreover, this excess was even greater in IFN-treated cells because of the inhibition of virus particle release so that it is unlikely that the reduced incorporation of G and M proteins into VSVIF was due to an insufficient concentration of these two membrane proteins, but rather to a specific inhibition in the utilization of the available G and M proteins in the assembly process.
The dolicolqinked oligosaccharide is the carbohydrate chain donor in the glycosylation of the VSV G protein (Robbins et al., 1977; Hunt et al., 1978; Tabas et al., 1978) . The first step in the synthesis of this glycolipid is the transfer of the first N-acetylglucosamine-l-phosphate from UDP-N-acetylglucosamine to dolicol monophosphate to form N-acetylglucosaminyl-pyrophosphoryldolicol (GlcNac-P-P-Dol). Maheshwari et al. (1980a) have reported that the enzymic activity for the synthesis of this first glycolipid intermediate associated with the membrane of the IFN-treated cell was reduced. If the reduction of this activity caused a deficiency in the level of glycosylation, the diminished virion production, and the reduced infectivity of the progeny virion, IFN treatment would have inhibited the formation of the carbohydrate chain (or substrate) necessary for the polypeptide glycosylation process, resulting in a reduction in the mol. wt. of the underglycosylated G protein; however, the mol. wt. of the G protein, from IFNtreated cells as analysed by SDS-PAGE (Fig. I a) and 2D-PAGE (Fig. 1 b) was identical to that of the G protein from control cells. Tunicamycin, which is known to inhibit the synthesis of GIcNAc-P-P-Dol specifically would have the same effect as IFN treatment, if IFN also inhibited glycosylation. A 2D-PAGE analysis of the VSV proteins from a virion produced in the presence of tunicamycin (Fig. 1 b, b) demonstrated the presence of the unglycosylated G polypeptide, pG, and several minor species of underglycosylated G intermediate with various amounts of carbohydrate. Such intermediates in glycosylation have not been observed in our studies with IFN. In fact, as Fig. 1 (b), d, shows, all the G-related species, detectable in a 7 min pulse-labelling of IFN-treated cells, are already fully glycosylated with the neutral sugars, so that no pG or glycosylation intermediate was detected. This indicated that the remaining enzyme activity was sufficient to keep up with the rate of polypeptide translation, and that the 40 to 60 % suppression of this enzyme activity by IFN (Maheshwari et al., 1980a) , was not directly involved in the antiviral mechanism in this system. In summary, the degradation rate of the virus proteins, as well as the rate and extent of glycosylation of the G protein were not affected by the IFN treatment; however, the rate of synthesis of the virus proteins in the IFN-treated cell was reduced. This was probably responsible for the reduced level of accumulation of VSV polypeptides after IFN treatment. This reduction in overall virus protein synthesis and accumulation may account for the proportionally reduced yield of progeny virions (less than 10-fold) from the IFN-treated cells; however, the specific deficiency of the membrane proteins, G and M, in the defective progeny VSVIF is difficult to account for, because the synthesis of these VSV proteins was not inhibited more than the other virus proteins. Indeed, the relative amounts of M protein accumulated was significantly increased in IFN-treated cells. Since the amount of VSV protein synthesized and accumulated in the control cell was more than ten times the amount incorporated into the released virion, in control cells the rate-limiting step in the infectious cycle of VSV appeared to be later than the synthesis and maturation of the viral proteins, and is probably virion assembly. In the IFN-treated cell, this step was further reduced by approximately threefold relative to the rate of virus protein synthesis, so that the amount of virus protein synthesized was at least 30 times in excess of the amount used. The results presented indicate that the IFN-induced antiviral mechanism cannot be due to an insufficient amount of mature virus membrane proteins for incorporation into virions, but is likely due to specific inhibition of incorporation of the G and M proteins into VSVIF as a result of IFN treatment.
